রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন*
Indications:
FERISEN 500 MG/10 ML is indicated for:
Iron deficiency anemia in patients with chronic kidney disease (CKD)
Iron deficiency in patients who are intolerant to or unresponsive to oral iron
Rapid iron repletion in cases of severe anemia or during pregnancy (as advised)
Pharmacology:
This preparation contains Iron Sucrose, a water-soluble, polynuclear iron(III)-hydroxide complex with sucrose. Following IV administration, it is processed by the reticuloendothelial system and incorporated into hemoglobin and other iron-containing components.
Dosage & Administration:
Administered intravenously only, either via slow IV injection or IV infusion
Usual dose: 100–200 mg per session; 500 mg may be given as a single infusion if clinically justified
Dilute with 0.9% sodium chloride and infuse over at least 15–30 minutes
Always perform test dose in sensitive patients and monitor closely
Interaction:
Avoid concurrent use with oral iron supplements
May interfere with lab tests related to iron metabolism (e.g., serum iron, ferritin)
Contraindications:
Hypersensitivity to iron sucrose or any component
Iron overload (e.g., hemochromatosis)
Non–iron deficiency anemia (e.g., hemolytic anemia)
Side Effects:
Common: Metallic taste, nausea, headache, injection site irritation
Less common: Hypotension, dizziness, back pain
Rare: Anaphylaxis, chest tightness, edema
Pregnancy & Lactation:
Can be used during pregnancy when benefits outweigh potential risks (Category B)
Use with caution during breastfeeding—minimal risk expected
Precautions & Warnings:
Always monitor for hypersensitivity reactions—resuscitation support should be available
Regularly check serum ferritin and hemoglobin levels
Avoid overdosage and unnecessary iron loading
Caution in patients with liver disease, asthma, or known allergies
Therapeutic Class:
Parenteral Iron Preparations
Storage Conditions:
Store below 25°C. Protect from light. Do not freeze. Keep out of reach of children.